Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
X
XBI
State Street SPDR S&P Biotech ETF
136.2
0
USD
+9917.65%
Sector:
Financial
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+9917.65%
Monthly Change
+5.17%
6 month change
+11.88%
Year Change
+23.67%
Previous Close
1.3
6
Open
136.4
8
Low
136.1
5
High
136.7
3
Volume
649
Markets
US ETFs
XBI
Open full chart
Full chart
Overview
All holdings
Heatmap
Top holdings
Market Value
Shares
Weight %
F
FOLD
Amicus Therapeutics Inc
117.0 M
8.2 M
1.5%
PRAX
Praxis Precision Medicines Inc
109.2 M
370.4 K
1.4%
TVTX
Travere Therapeutics Inc
107.7 M
2.8 M
1.4%
BMRN
BioMarin Pharmaceutical Inc
107.2 M
1.8 M
1.4%
HALO
Halozyme Therapeutics Inc
104.1 M
1.5 M
1.3%
ROIV
Roivant Sciences Ltd
103.9 M
4.8 M
1.3%
EXEL
Exelixis Inc
103.4 M
2.4 M
1.3%
REGN
Regeneron Pharmaceuticals Inc
103.0 M
133.4 K
1.3%
PCVX
Vaxcyte Inc
102.8 M
2.2 M
1.3%
MDGL
Madrigal Pharmaceuticals Inc
102.1 M
175.4 K
1.3%
CYTK
Cytokinetics Inc
102.1 M
1.6 M
1.3%
BBIO
Bridgebio Pharma Inc
102.0 M
1.3 M
1.3%
AMGN
Amgen Inc
100.6 M
307.3 K
1.3%
INCY
Incyte Corp
100.6 M
1.0 M
1.3%
KRYS
Krystal Biotech Inc
99.7 M
404.2 K
1.3%
PTCT
PTC Therapeutics Inc
99.3 M
1.3 M
1.3%
RVMD
Revolution Medicines Inc
99.1 M
1.2 M
1.3%
RYTM
Rhythm Pharmaceuticals Inc
99.0 M
925.0 K
1.3%
VRTX
Vertex Pharmaceuticals Inc
98.8 M
217.9 K
1.3%
MRNA
Moderna Inc
98.4 M
3.3 M
1.3%
1
2
3
4
5
6
7
8
News
First Quarter Earnings: Sharpening Sector Divergence
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Biotech Investors Are Tuning Out the MAHA Chaos
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable (MRVI)
FDA Commissioner Marty Makary Expected To Resign, Ending Turbulent Stint
Why I Now Favor A Barbell Model Over Ray Dalio’s All-Weather Portfolio (SPY)
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Why This Biotech ETF — The IBD Stock Of The Day — Just Reentered Its Buy Zone
Broadcom, Google And Caterpillar Lead AI Charge On Must-See List